St. Jude Medical Inc (NYSE:STJ)

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It operates through two operating divisions: Cardiovascular & Ablation Technologies and Electronic Systems Division. The Cardiovascular & Ablation Technologies Division combining legacy Cardiovascular and Atrial Fibrillation product divisions. The Implantable Electronic Systems Division combining Cardiac Rhythm Management and Neuromodulation product divisions. Its products in each therapy area are as follows: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems and bradycardia pacemaker systems; Cardiovascular - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation - electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems; and Neuromodulation - neurostimulation products, which include spinal cord and deep brain stimulation devices. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN.